Search - tctmd.com

Displaying 901 - 920 of 1517

Sort: Relevancy | Date

ESC Updates Guidelines for Treating STEMI Patients

News Conference News ESC 2017

ESC Updates Guidelines for Treating STEMI Patients

Michael O'Riordan

August 27, 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

News Conference News ESC 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Michael O'Riordan

August 27, 2017

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

News Conference News ESC 2017

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

August 27, 2017

Underweight and Overlooked: Low BMI Patients May Be Highest-Risk Post-PCI

News Conference News ESC 2017

Underweight and Overlooked: Low BMI Patients May Be Highest-Risk Post-PCI

August 26, 2017

CDC Says Only One in Three Post-MI Patients Get Outpatient Cardiac Rehab

News Daily News

CDC Says Only One in Three Post-MI Patients Get Outpatient Cardiac Rehab

August 25, 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On, With Hotly Anticipated Trials

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

August 18, 2017

Fibrinolytic Agents for STEMI: Meta-analysis Explores the Differences

News Daily News

Fibrinolytic Agents for STEMI: Meta-analysis Explores the Differences

August 18, 2017

How Alcohol Hurts and Harms: CVD Sweet Spot Confirmed Anew in Large Meta-Analysis

News Daily News

How Alcohol Hurts and Harms: CVD Sweet Spot Confirmed Anew in Large Meta-Analysis

August 15, 2017

Reusing the Radial: Repeat Transradial Access Safe and Feasible, Even Within 24 Hours

News Daily News

Reusing the Radial: Repeat Transradial Access Safe and Feasible, Even Within 24 Hours

Michael O'Riordan

August 09, 2017

Readmissions After Acute MI Not Only Confined to the Elderly

News Daily News

Readmissions After Acute MI Not Only Confined to the Elderly

Yael L. Maxwell

August 09, 2017

Money-Back Guarantee for Evolocumab Has Little Impact on Cost-Effectiveness

News Daily News

Money-Back Guarantee for Evolocumab Has Little Impact on Cost-Effectiveness

Michael O'Riordan

August 08, 2017

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

News Daily News

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

Michael O'Riordan

August 04, 2017

Elevated Cardiovascular Risk May Linger for Several Years After a Severe Infection

News Daily News

Elevated Cardiovascular Risk May Linger for Several Years After a Severe Infection

August 02, 2017

‘Remnant’ Cholesterol Linked With CVD Risk, Even When LDL Levels Are Low

News Daily News

‘Remnant’ Cholesterol Linked With CVD Risk, Even When LDL Levels Are Low

Michael O'Riordan

August 01, 2017

Despite the Strengths of Next-Gen DES, BMS Deserve a Place at the Cath Table, Review Asserts

News Daily News

Despite the Strengths of Next-Gen DES, BMS Deserve a Place at the Cath Table, Review Asserts

July 28, 2017

E-Cigarettes Aid in Smoking Cessation, US Study Suggests

News Daily News

E-Cigarettes Aid in Smoking Cessation, US Study Suggests

Michael O'Riordan

July 27, 2017

Genetic Study Supports Link Between Serum Calcium and CAD Risk

News Daily News

Genetic Study Supports Link Between Serum Calcium and CAD Risk

July 26, 2017

Staying on Statins After an Adverse Event Lowers Risks of Death, MI or Stroke

News Daily News

Staying on Statins After an Adverse Event Lowers Risks of Death, MI or Stroke

Michael O'Riordan

July 25, 2017

Long-term Ticagrelor Post-MI of ‘Intermediate Value’: Cost-Effectiveness Study

News Daily News

Long-term Ticagrelor Post-MI of ‘Intermediate Value’: Cost-Effectiveness Study

July 24, 2017

Higher In-Hospital Mortality After STEMI Linked to Lack of Health Insurance

News Daily News

Higher In-Hospital Mortality After STEMI Linked to Lack of Health Insurance

July 20, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.